PureTech Health (NASDAQ:PRTC) Trading Up 9%

PureTech Health plc (NASDAQ:PRTC) shares shot up 9% on Monday . The company traded as high as $22.20 and last traded at $22.20. 4,777 shares traded hands during mid-day trading, an increase of 56% from the average session volume of 3,062 shares. The stock had previously closed at $20.36.

Analyst Upgrades and Downgrades

A number of research analysts have recently weighed in on PRTC shares. Leerink Partnrs raised shares of PureTech Health to a “strong-buy” rating in a research report on Monday. Leerink Partners began coverage on PureTech Health in a research report on Monday. They issued an “outperform” rating and a $45.00 target price for the company.

PureTech Health Trading Up 0.5 %

The company’s fifty day simple moving average is $22.32 and its 200 day simple moving average is $25.72.

Institutional Trading of PureTech Health

A hedge fund recently bought a new stake in PureTech Health stock. AWM Investment Company Inc. acquired a new position in PureTech Health plc (NASDAQ:PRTC) during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm acquired 6,900 shares of the company’s stock, valued at approximately $197,000. 0.04% of the stock is currently owned by institutional investors.

About PureTech Health

PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. The company is developing LYT-100, which is under Phase 2 stage, to treat idiopathic pulmonary fibrosis (IPF); and LYT-200, a IgG4 monoclonal antibody, currently under Phase 1/2 stage, targeting galectin-9 for treating solid tumors and hematological malignancies.